Deregulation of NF-кB-miR-146a negative feedback loop may be involved in the pathogenesis of diabetic neuropathy. (Q53643581)

16 May 2018

title

Deregulation of NF-кB-miR-146a negative feedback loop may be involved in the pathogenesis of diabetic neuropathy. (English)

1 reference

16 May 2018

author

Mohammad Reza Alipour

series ordinal

2

1 reference

16 May 2018

author name string

Nasibeh Yousefzadeh

series ordinal

1

1 reference

16 May 2018

Farhad Ghadiri Soufi

series ordinal

3

1 reference

16 May 2018

publication date

8 January 2015

1 reference

16 May 2018

Journal of Physiology and Biochemistry

published in

1 reference

16 May 2018

volume

71

1 reference

16 May 2018

issue

1

1 reference

16 May 2018

page(s)

51-58

1 reference

16 May 2018

https://scigraph.springernature.com/pub.10.1007/s13105-014-0378-4

exact match

0 references

cites work

Upregulation of microRNA-146a was not accompanied by downregulation of pro-inflammatory markers in diabetic kidney.

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

MicroRNAs: new regulators of immune cell development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Diabetic neuropathy: mechanisms to management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Mechanisms of diabetic complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

NF-kappaB in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

MicroRNAs in NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

NF-kappaB in neuronal plasticity and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Physiological functions for brain NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Nrf2 and NF-κB modulation by sulforaphane counteracts multiple manifestations of diabetic neuropathy in rats and high glucose-induced changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Resveratrol induces nuclear factor-κB activity in human cardiac cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Role of NF-kappa B in the pathogenesis of diabetes and its associated complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

A trio of microRNAs that control Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Oxidative stress, insulin signaling, and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Mechanisms underlying vascular effect of chronic resveratrol in streptozotocin-diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

NF-kappaB in renal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Effect of alcohol on blood glucose and antioxidant enzymes in the liver and kidney of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor κB - apoptosis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

MicroRNAs modulate the dynamics of the NF-κB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0378-4

Antihyperglycemic effect of umbelliferone in streptozotocin-diabetic rats

21 January 2018

1 reference

12 December 2020

Inflammation and NF-kappaB in Alzheimer's disease and diabetes.

1 reference

12 December 2020

MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice

1 reference

12 December 2020

Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment

1 reference

12 December 2020

10.1007/S13105-014-0378-4

Identifiers

DOI

1 reference

16 May 2018

PubMed ID

25567745

1 reference

16 May 2018